340 related articles for article (PubMed ID: 17304503)
1. Soy isoflavones enhance radiotherapy in a metastatic prostate cancer model.
Raffoul JJ; Banerjee S; Che M; Knoll ZE; Doerge DR; Abrams J; Kucuk O; Sarkar FH; Hillman GG
Int J Cancer; 2007 Jun; 120(11):2491-8. PubMed ID: 17304503
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of apurinic/apyrimidinic endonuclease 1/redox factor-1 expression by soy isoflavones enhances prostate cancer radiotherapy in vitro and in vivo.
Raffoul JJ; Banerjee S; Singh-Gupta V; Knoll ZE; Fite A; Zhang H; Abrams J; Sarkar FH; Hillman GG
Cancer Res; 2007 Mar; 67(5):2141-9. PubMed ID: 17332344
[TBL] [Abstract][Full Text] [Related]
3. Daidzein effect on hormone refractory prostate cancer in vitro and in vivo compared to genistein and soy extract: potentiation of radiotherapy.
Singh-Gupta V; Zhang H; Yunker CK; Ahmad Z; Zwier D; Sarkar FH; Hillman GG
Pharm Res; 2010 Jun; 27(6):1115-27. PubMed ID: 20309614
[TBL] [Abstract][Full Text] [Related]
4. Prostate cancer treatment is enhanced by genistein in vitro and in vivo in a syngeneic orthotopic tumor model.
Wang Y; Raffoul JJ; Che M; Doerge DR; Joiner MC; Kucuk O; Sarkar FH; Hillman GG
Radiat Res; 2006 Jul; 166(1 Pt 1):73-80. PubMed ID: 16808622
[TBL] [Abstract][Full Text] [Related]
5. Combination of low dose of genistein and daidzein has synergistic preventive effects on isogenic human prostate cancer cells when compared with individual soy isoflavone.
Dong X; Xu W; Sikes RA; Wu C
Food Chem; 2013 Dec; 141(3):1923-33. PubMed ID: 23870911
[TBL] [Abstract][Full Text] [Related]
6. Individual and combined soy isoflavones exert differential effects on metastatic cancer progression.
Martínez-Montemayor MM; Otero-Franqui E; Martinez J; De La Mota-Peynado A; Cubano LA; Dharmawardhane S
Clin Exp Metastasis; 2010 Oct; 27(7):465-80. PubMed ID: 20517637
[TBL] [Abstract][Full Text] [Related]
7. Genistein potentiates inhibition of tumor growth by radiation in a prostate cancer orthotopic model.
Hillman GG; Wang Y; Kucuk O; Che M; Doerge DR; Yudelev M; Joiner MC; Marples B; Forman JD; Sarkar FH
Mol Cancer Ther; 2004 Oct; 3(10):1271-9. PubMed ID: 15486194
[TBL] [Abstract][Full Text] [Related]
8. DNA methylation and soy phytoestrogens: quantitative study in DU-145 and PC-3 human prostate cancer cell lines.
Adjakly M; Bosviel R; Rabiau N; Boiteux JP; Bignon YJ; Guy L; Bernard-Gallon D
Epigenomics; 2011 Dec; 3(6):795-803. PubMed ID: 22126297
[TBL] [Abstract][Full Text] [Related]
9. Lack of combination effects of soy isoflavones and taxane chemotherapy of castration-resistant prostate cancer.
Eskra JN; Schlicht MJ; Bosland MC
Prostate; 2019 Feb; 79(2):223-233. PubMed ID: 30345530
[TBL] [Abstract][Full Text] [Related]
10. Soy isoflavones augment the effect of TRAIL-mediated apoptotic death in prostate cancer cells.
Szliszka E; Krol W
Oncol Rep; 2011 Sep; 26(3):533-41. PubMed ID: 21637922
[TBL] [Abstract][Full Text] [Related]
11. Progression of renal cell carcinoma is inhibited by genistein and radiation in an orthotopic model.
Hillman GG; Wang Y; Che M; Raffoul JJ; Yudelev M; Kucuk O; Sarkar FH
BMC Cancer; 2007 Jan; 7():4. PubMed ID: 17212824
[TBL] [Abstract][Full Text] [Related]
12. Suppression of VEGF-mediated autocrine and paracrine interactions between prostate cancer cells and vascular endothelial cells by soy isoflavones.
Guo Y; Wang S; Hoot DR; Clinton SK
J Nutr Biochem; 2007 Jun; 18(6):408-17. PubMed ID: 17142033
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of whole soy extract and soy isoflavones on apoptosis in prostate cancer cells.
Hsu A; Bray TM; Helferich WG; Doerge DR; Ho E
Exp Biol Med (Maywood); 2010 Jan; 235(1):90-7. PubMed ID: 20404023
[TBL] [Abstract][Full Text] [Related]
14. Radiation-induced HIF-1alpha cell survival pathway is inhibited by soy isoflavones in prostate cancer cells.
Singh-Gupta V; Zhang H; Banerjee S; Kong D; Raffoul JJ; Sarkar FH; Hillman GG
Int J Cancer; 2009 Apr; 124(7):1675-84. PubMed ID: 19101986
[TBL] [Abstract][Full Text] [Related]
15. Clinical characteristics and pharmacokinetics of purified soy isoflavones: multiple-dose administration to men with prostate neoplasia.
Fischer L; Mahoney C; Jeffcoat AR; Koch MA; Thomas BE; Valentine JL; Stinchcombe T; Boan J; Crowell JA; Zeisel SH
Nutr Cancer; 2004; 48(2):160-70. PubMed ID: 15231450
[TBL] [Abstract][Full Text] [Related]
16. Apoptotic effects of cooked and in vitro digested soy on human prostate cancer cells.
Dong X; Xu W; Sikes RA; Wu C
Food Chem; 2012 Dec; 135(3):1643-52. PubMed ID: 22953905
[TBL] [Abstract][Full Text] [Related]
17. Effects of soy isoflavones on apoptosis induction and G2-M arrest in human hepatoma cells involvement of caspase-3 activation, Bcl-2 and Bcl-XL downregulation, and Cdc2 kinase activity.
Su SJ; Chow NH; Kung ML; Hung TC; Chang KL
Nutr Cancer; 2003; 45(1):113-23. PubMed ID: 12791511
[TBL] [Abstract][Full Text] [Related]
18. Soy isoflavonoid equol modulates the growth of benign and malignant prostatic epithelial cells in vitro.
Hedlund TE; Johannes WU; Miller GJ
Prostate; 2003 Jan; 54(1):68-78. PubMed ID: 12481257
[TBL] [Abstract][Full Text] [Related]
19. Membrane fluidity, invasiveness and dynamic phenotype of metastatic prostate cancer cells after treatment with soy isoflavones.
Ajdžanović V; Mojić M; Maksimović-Ivanić D; Bulatović M; Mijatović S; Milošević V; Spasojević I
J Membr Biol; 2013 Apr; 246(4):307-14. PubMed ID: 23417033
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of murine bladder tumorigenesis by soy isoflavones via alterations in the cell cycle, apoptosis, and angiogenesis.
Zhou JR; Mukherjee P; Gugger ET; Tanaka T; Blackburn GL; Clinton SK
Cancer Res; 1998 Nov; 58(22):5231-8. PubMed ID: 9823337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]